ANA
BERNAL CHICO
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas
Madrid, EspañaPublications en collaboration avec des chercheurs de Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (9)
2024
-
Autoimmune inflammation triggers aberrant astrocytic calcium signaling to impair synaptic plasticity
Brain, Behavior, and Immunity, Vol. 121, pp. 192-210
2023
-
Endocannabinoid signaling in brain diseases: Emerging relevance of glial cells
GLIA, Vol. 71, Núm. 1, pp. 103-126
-
The endocannabinoid system and autoimmune demyelination: A focus on multiple sclerosis
Neurobiology and Physiology of the Endocannabinoid System (Elsevier), pp. 229-240
2021
-
Δ9-Tetrahydrocannabinol promotes oligodendrocyte development and CNS myelination in vivo
GLIA, Vol. 69, Núm. 3, pp. 532-545
2020
-
Gene expression analysis of astrocyte and microglia endocannabinoid signaling during autoimmune demyelination
Biomolecules, Vol. 10, Núm. 9, pp. 1-19
-
P2x7 receptors control demyelination and inflammation in the cuprizone model
Brain, Behavior, and Immunity - Health, Vol. 4
2018
-
Deregulation of the endocannabinoid system and therapeutic potential of ABHD6 blockade in the cuprizone model of demyelination
Biochemical Pharmacology, Vol. 157, pp. 189-201
-
Re-examining the potential of targeting ABHD6 in multiple sclerosis: Efficacy of systemic and peripherally restricted inhibitors in experimental autoimmune encephalomyelitis
Neuropharmacology, Vol. 141, pp. 181-191
2015
-
Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo
GLIA, Vol. 63, Núm. 1, pp. 163-176